APA (7th ed.) Citation

Farace, F., Mathiot, C., Brandely, M., Tursz, T., Dorval, T., Pouillart, P., . . . Fridman, W. H. (1990). Phase I trial with recombinant interleukin-2 (rIL-2): Immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma. Clinical & Experimental Immunology, 82(2), 194.

Chicago Style (17th ed.) Citation

Farace, F., C. Mathiot, M. Brandely, T. Tursz, T. Dorval, P. Pouillart, F. Triebel, T. Hercend, and W. H. Fridman. "Phase I Trial with Recombinant Interleukin-2 (rIL-2): Immune Activation by RIL-2 Alone or Following Pretreatment with Recombinant Interferon-gamma." Clinical & Experimental Immunology 82, no. 2 (1990): 194.

MLA (9th ed.) Citation

Farace, F., et al. "Phase I Trial with Recombinant Interleukin-2 (rIL-2): Immune Activation by RIL-2 Alone or Following Pretreatment with Recombinant Interferon-gamma." Clinical & Experimental Immunology, vol. 82, no. 2, 1990, p. 194.